In addition to the definitions in K.S.A. 65-1,201 and amendments thereto, each of the following terms shall have the meaning assigned in this regulation: (a) "Elevated blood lead level (EBL) child" and "EBL child" mean any child who has an excessive absorption of lead with a confirmed concentration of lead in whole blood of 10 μg (micrograms) of lead per deciliter of whole blood, as specified in K.A.R. 28-1-18.

1. (b) "Encapsulant" means a substance that forms a barrier between lead-based paint and the environment using a liquid-applied coating, with or without reinforcement materials, or an adhesively bonded covering material.
2. (c) "Encapsulation" means the application of an encapsulant.
3. (d) "Enclosure" has the meaning specified in 40 CFR 745.223, as adopted in K.A.R. 28-72-2.
4. (e) "EPA" means the United States environmental protection agency.

(Authorized by and implementing K.S.A. 65-1,202; effective April 9, 2010.)